Company Filing History:
Years Active: 2018-2019
Title: The Innovative Contributions of Huan-Qui Li in Immunology and Oncology
Introduction
Huan-Qui Li, an accomplished inventor based in Wilmette, Illinois, has made significant strides in the fields of immunology and oncology. With a total of two patents to his name, he continues to push the boundaries of medical science through his innovative approaches.
Latest Patents
Huan-Qui Li’s latest patents focus on tricyclic modulators of TNF signaling. These inventions provide tricyclic heterocyclic compounds, which include pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers. The compounds specified in his patents hold promise for treating a variety of immunological and oncological conditions, showcasing the potential to enhance therapies in these critical areas.
Career Highlights
Currently, Huan-Qui Li is associated with AbbVie Inc., a leading biopharmaceutical company known for its commitment to developing advanced therapies. His work at AbbVie has been instrumental in furthering research that combines biological science with innovative drug development, particularly in the treatment of complex diseases.
Collaborations
In his professional journey, Huan-Qui Li has collaborated with esteemed colleagues such as Eric C. Breinlinger and Phil B. Cox. These partnerships exemplify the collaborative spirit of innovation, bringing together diverse expertise to enhance the effectiveness of their research endeavors.
Conclusion
Huan-Qui Li's contributions to the field of pharmaceutical science, particularly through his patents on tricyclic modulators of TNF signaling, underline the importance of innovative thinking in tackling significant health challenges. As he continues his work at AbbVie Inc., the medical community eagerly anticipates the potential impact of his inventions on the treatment of immunological and oncological conditions.